749 related articles for article (PubMed ID: 18656589)
1. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Er H
Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
[No Abstract] [Full Text] [Related]
2. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Kang SW; Park SC; Cho HY; Kang JH
Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
[TBL] [Abstract][Full Text] [Related]
3. Diabetic macular edema.
Jonas J; Rensch F
Ophthalmology; 2009 Mar; 116(3):594-5; author reply 596-7. PubMed ID: 19264219
[No Abstract] [Full Text] [Related]
4. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
5. Diabetic macular edema.
Gillies M
Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
[No Abstract] [Full Text] [Related]
6. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
Ophthalmology; 2011 May; 118(5):866-72. PubMed ID: 21232801
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema.
Narula R; Agarwal M; Chaudhary SP; Shroff C
Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
[No Abstract] [Full Text] [Related]
9. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
10. Diabetic macular edema.
Kim SJ
Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
[No Abstract] [Full Text] [Related]
11. Correspondence.
Lorenzo-Carrero J
Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
[No Abstract] [Full Text] [Related]
12. DRCR Study: outcomes in focal vs diffuse edema?
Blanco-Garavito R; Rodriguez-Valdes PJ
Ophthalmology; 2009 Mar; 116(3):595-6; author reply 596-7. PubMed ID: 19264221
[No Abstract] [Full Text] [Related]
13. Intravitreal triamcinolone.
Gillies MC; Simpson JM; Zhu M; Hunt G; Ali H; Gaston C
Ophthalmology; 2009 Mar; 116(3):591. PubMed ID: 19264215
[No Abstract] [Full Text] [Related]
14. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Ho TC; Lai WW; Lam DS
Am J Ophthalmol; 2006 Apr; 141(4):786-7; author reply 787-8. PubMed ID: 16564847
[No Abstract] [Full Text] [Related]
15. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Sarici A; Muftuoglu G
Am J Ophthalmol; 2006 Apr; 141(4):785-6; author reply 786. PubMed ID: 16564845
[No Abstract] [Full Text] [Related]
16. Macular edema treatment.
Salti HI; Khoury J; Khairallah N; Hamam R
Ophthalmology; 2006 May; 113(5):885; author reply 885-6. PubMed ID: 16650688
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
Kytö JP; Angerman S; Lumiste E; Paloheimo M; Summanen PA
Acta Ophthalmol Scand; 2005 Oct; 83(5):605-8. PubMed ID: 16188001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
